Macrogenics (MGNX) Stock Price, Quote & News

Company Profile

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic can...

Industry: Biotechnology

Sector: Healthcare

Phone: 301 251 5172

Fax: 301 251 5321

Website: www.macrogenics.com

Address:

9704 Medical Center Drive, Rockville, United States

Budman10 Aug. 7 at 10:33 PM

$MGNX the safety numbers are so compelling. Let’s hope ORR doesn’t disappoint. Easy $1 billion market cap of it comes through

0 · Reply

philmori Aug. 6 at 9:10 PM

$MGNX the price stay the same... Cooking evident.

0 · Reply

philmori Aug. 6 at 5:56 PM

$MGNX got in... noticed the special trade patterns.

1 · Reply

Budman10 Aug. 4 at 1:08 AM

$MGNX we need to wait till end of October for ESMO. Interesting next few months. What to Look For at ESMO when the exact percentages are unblinded at ESMO, an interim ORR of 15% to 20% will represent a "borderline pass"—meaning the drug is active but will face intense competition. An interim ORR printing at 25% to 35% in this refractory population will establish MGC026 as a major clinical success, especially given its pristine, 0% interstitial lung disease safety profile

0 · Reply

AlertsAndNews Jul. 30 at 8:06 PM

$MGNX popping here 13G yesterday.

1 · Reply

elmono Jul. 28 at 2:17 PM

$MGNX super bounce 😂😂😂

0 · Reply

PSDL75 Jul. 27 at 7:40 PM

$MGNX nice bounce after the attack fri

0 · Reply

FindFunds Jul. 27 at 7:23 PM

$MGNX how are we feeling about the prospects lately?

0 · Reply

Budman10 Jul. 24 at 9:36 PM

$MGNX why would management announce move to stage 2 if they didn’t think ORR results would be at a level acceptable. I think we will see solid numbers. We already are seeing that safety is solid so far.

1 · Reply

chole1 Jul. 24 at 7:14 PM

$MGNX independent of today's disappointing update... like clockwork, at 3/3:15 starts the intraday sell-off. With MGNX not in indices any more, what is the reason? Options gaming? tx

1 · Reply

MacroGenics provides update on MGC026 study

Jul 23, 2026, 4:01 PM EDT - 15 days ago

MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

Jul 23, 2026, 8:00 AM EDT - 15 days ago

MacroGenics Slides: Corporate presentation

Jul 2, 2026, 9:25 AM EDT - 5 weeks ago

MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals

2026-06-22T20:45:10.000Z - 6 weeks ago

MacroGenics to receive $24.5M milestone payment from Sanofi

SNY

Jun 22, 2026, 4:43 PM EDT - 6 weeks ago

MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval

May 20, 2026, 10:30 AM EDT - 2 months ago

MacroGenics Transcript: Stifel 2026 Targeted Oncology Virtual Forum

May 14, 2026, 4:01 PM EDT - 3 months ago

MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum

2026-05-13T20:39:44.000Z - 3 months ago

MacroGenics reports Q1 EPS (58c), consensus (55c)

May 13, 2026, 4:01 PM EDT - 3 months ago

MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation

May 13, 2026, 7:00 AM EDT - 3 months ago

MacroGenics Quarterly report: Q1 2026

May 13, 2026, 7:00 AM EDT - 3 months ago

MacroGenics Earnings release: Q1 2026

2026-05-11T22:48:03.000Z - 3 months ago

MacroGenics to sell GMP manufacturing operations to Bora for $122.5M upfront

2026-05-11T22:40:45.000Z - 3 months ago

MacroGenics trading resumes

May 11, 2026, 5:20 PM EDT - 3 months ago

MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals

2026-05-11T20:33:29.000Z - 3 months ago

MacroGenics trading halted, news pending

2026-05-04T11:49:28.000Z - 3 months ago

MacroGenics, Sagard enter expanded Zynyz royalty purchase agreement

INCY

May 4, 2026, 7:30 AM EDT - 3 months ago

MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement

Apr 22, 2026, 8:00 AM EDT - 3 months ago

MacroGenics Proxy statement: Proxy filing

2026-04-20T09:25:08.000Z - 3 months ago

MacroGenics price target raised to $6 from $4 at Barclays

2026-04-10T11:06:12.000Z - 4 months ago

MacroGenics upgraded to Buy at B. Riley after deal for Tubulus

GILD

2026-04-10T10:55:12.000Z - 4 months ago

MacroGenics upgraded to Buy from Neutral at B. Riley

2026-04-08T20:37:37.000Z - 4 months ago

MacroGenics says FDA removes partial clinical hold on Phase 2 LINNET study

Apr 8, 2026, 4:30 PM EDT - 4 months ago

FDA Removes Partial Clinical Hold on MacroGenics' LINNET Study

Apr 8, 2026, 8:00 AM EDT - 4 months ago

MacroGenics Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 4 months ago

MacroGenics Proxy statement: Proxy filing

Mar 12, 2026, 10:00 AM EDT - 5 months ago

MacroGenics Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 11, 2026, 10:45 AM EDT - 5 months ago

MacroGenics Transcript: The Citizens Life Sciences Conference 2026

Mar 10, 2026, 1:40 PM EDT - 5 months ago

MacroGenics Transcript: Leerink Global Healthcare Conference 2026

2026-03-10T09:15:35.000Z - 5 months ago

MacroGenics price target raised to $4 from $3 at Barclays

Mar 9, 2026, 4:01 PM EDT - 5 months ago

MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures

Mar 9, 2026, 7:00 AM EDT - 5 months ago

MacroGenics Earnings release: Q4 2025

Mar 9, 2026, 7:00 AM EDT - 5 months ago

MacroGenics Annual report: Q4 2025

Mar 9, 2026, 7:00 AM EDT - 5 months ago

MacroGenics Slides: Corporate presentation

Mar 3, 2026, 3:10 PM EST - 5 months ago

MacroGenics Transcript: TD Cowen 46th Annual Health Care Conference

Feb 26, 2026, 5:30 PM EST - 5 months ago

MacroGenics to Participate in Upcoming Investor Conferences

2026-02-23T23:20:15.000Z - 5 months ago

MacroGenics says FDA places partial clinical hold on Phase 2 LINNET study

Feb 23, 2026, 6:14 PM EST - 5 months ago

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial

Dec 4, 2025, 7:55 AM EST - 8 months ago

MacroGenics Transcript: Evercore ISI 8th Annual HealthCONx Conference

Nov 25, 2025, 4:05 PM EST - 9 months ago

MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference

Nov 13, 2025, 4:00 PM EST - 9 months ago

MacroGenics Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 6:00 PM EST - 9 months ago

MacroGenics Slides: Corporate Presentation

2025-11-12T21:23:19.000Z - 9 months ago

MacroGenics reports Q3 EPS 27c vs 90c last year

2025-11-12T21:22:50.000Z - 9 months ago

MacroGenics expects cash to fund operations into late 2027

Nov 12, 2025, 4:01 PM EST - 9 months ago

MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress

Nov 12, 2025, 2:30 AM EST - 9 months ago

MacroGenics Earnings release: Q3 2025

Nov 12, 2025, 2:30 AM EST - 9 months ago

MacroGenics Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

MacroGenics to Participate in the Stifel 2025 Healthcare Conference

2025-09-16T20:50:19.000Z - 11 months ago

MacroGenics assumed with an Overweight at Barclays

2025-09-16T20:20:17.000Z - 11 months ago

MacroGenics initiated with an Overweight at Barclays

Sep 8, 2025, 11:30 AM EDT - 11 months ago

MacroGenics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 4:30 PM EDT - 1 year ago

MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference

2025-08-15T11:35:33.000Z - 1 year ago

MacroGenics price target lowered to $5 from $8 at Leerink

2025-08-14T20:12:11.000Z - 1 year ago

MacroGenics reports Q2 EPS (57c), consensus (38c)

Aug 14, 2025, 4:01 PM EDT - 1 year ago

MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities

Aug 14, 2025, 7:00 AM EDT - 1 year ago

MacroGenics Earnings release: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 1 year ago

MacroGenics Quarterly report: Q2 2025

Aug 13, 2025, 4:01 PM EDT - 1 year ago

MacroGenics Appoints Eric Risser as President and Chief Executive Officer

Jun 10, 2025, 8:00 AM EDT - 1 year ago

MacroGenics Transcript: Goldman Sachs 46th Annual Global Healthcare Conference 2025

Jun 10, 2025, 7:00 AM EDT - 1 year ago

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

Jun 10, 2025, 7:00 AM EDT - 1 year ago

MacroGenics Slides: Corporate Presentation

Jun 3, 2025, 4:30 PM EDT - 1 year ago

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

May 13, 2025, 4:01 PM EDT - 1 year ago

MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results

May 13, 2025, 3:30 AM EDT - 1 year ago

MacroGenics Earnings release: Q1 2025

May 13, 2025, 3:30 AM EDT - 1 year ago

MacroGenics Quarterly report: Q1 2025

May 8, 2025, 10:30 AM EDT - 1 year ago

MacroGenics Transcript: The Citizens JMP Life Sciences Conference 2025

May 6, 2025, 4:30 PM EDT - 1 year ago

MacroGenics Announces Date of First Quarter 2025 Financial Results

May 1, 2025, 4:30 PM EDT - 1 year ago

MacroGenics to Participate in Upcoming Investor Conference

Apr 11, 2025, 8:00 AM EDT - 1 year ago

MacroGenics Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

MacroGenics Proxy statement: Proxy Filing

Mar 19, 2025, 4:30 PM EDT - 1 year ago

MacroGenics Earnings Call Transcript: Q4 2024

Mar 19, 2025, 4:30 PM EDT - 1 year ago

MacroGenics Earnings release: Q4 2024

Mar 19, 2025, 4:30 PM EDT - 1 year ago

MacroGenics Annual report: Q4 2024

Mar 12, 2025, 2:00 PM EDT - 1 year ago

MacroGenics Transcript: Barclays 27th Annual Global Healthcare Conference

Mar 11, 2025, 11:20 AM EDT - 1 year ago

MacroGenics Transcript: Leerink’s Global Healthcare Conference 2025

Mar 6, 2025, 7:30 AM EST - 1 year ago

MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call

Mar 5, 2025, 10:30 AM EST - 1 year ago

MacroGenics Transcript: TD Cowen 45th Annual Healthcare Conference

Dec 4, 2024, 7:30 AM EST - 1 year ago

MacroGenics Transcript: 7th Annual Evercore ISI HealthCONx Healthcare Conference

Nov 18, 2024, 1:15 PM EST - 1 year ago

MacroGenics Transcript: Stifel 2024 Healthcare Conference

Nov 12, 2024, 4:00 PM EST - 1 year ago

MacroGenics Transcript: Guggenheim Securities Inaugural Healthcare Innovation Conference

Nov 5, 2024, 4:01 PM EST - 1 year ago

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

Nov 5, 2024, 2:30 AM EST - 1 year ago

MacroGenics Earnings Call Transcript: Q3 2024

Nov 5, 2024, 2:30 AM EST - 1 year ago

MacroGenics Earnings release: Q3 2024

Nov 5, 2024, 2:30 AM EST - 1 year ago

MacroGenics Quarterly report: Q3 2024

Oct 30, 2024, 7:30 AM EDT - 1 year ago

MacroGenics Announces Leadership Transition

Oct 29, 2024, 4:30 PM EDT - 1 year ago

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

Oct 25, 2024, 5:15 PM EDT - 1 year ago

Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders

Oct 22, 2024, 7:30 AM EDT - 1 year ago

MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®

Budman10 Aug. 7 at 10:33 PM

$MGNX the safety numbers are so compelling. Let’s hope ORR doesn’t disappoint. Easy $1 billion market cap of it comes through

0 · Reply

philmori Aug. 6 at 9:10 PM

$MGNX the price stay the same... Cooking evident.

0 · Reply

philmori Aug. 6 at 5:56 PM

$MGNX got in... noticed the special trade patterns.

1 · Reply

Budman10 Aug. 4 at 1:08 AM

0 · Reply

AlertsAndNews Jul. 30 at 8:06 PM

$MGNX popping here 13G yesterday.

1 · Reply

elmono Jul. 28 at 2:17 PM

$MGNX super bounce 😂😂😂

0 · Reply

PSDL75 Jul. 27 at 7:40 PM

$MGNX nice bounce after the attack fri

0 · Reply

FindFunds Jul. 27 at 7:23 PM

$MGNX how are we feeling about the prospects lately?

0 · Reply

Budman10 Jul. 24 at 9:36 PM

1 · Reply

chole1 Jul. 24 at 7:14 PM

$MGNX independent of today's disappointing update... like clockwork, at 3/3:15 starts the intraday sell-off. With MGNX not in indices any more, what is the reason? Options gaming? tx

1 · Reply

Budman10 Jul. 24 at 6:19 PM

$MGNX Efficacy data was withheld because of the ESMO meeting in October. So, today is profit taking/selling on the news. Medical journals and conferences impose strict "embargo" rules, meaning companies cannot publicly release specific percentages, charts, or breakdown metrics beforehand without risking disqualification from presenting at the event.

1 · Reply

Drugtrade Jul. 24 at 4:17 PM

$MGNX thats a hard dump good support at 3.30 have cash but will need more soon ofc

2 · Reply

Cello69 Jul. 24 at 4:04 PM

$MGNX This is bullshit

0 · Reply

PSDL75 Jul. 24 at 2:14 PM

$MGNX That 2.66 at the 200d is a bit scary - its pretty dead now dropping from the cloud..no supports

0 · Reply

chole1 Jul. 24 at 1:50 PM

$MGNX yet again I was wrong, had expected some efficacy data as well, now -100mn EV but no one will care for a while

0 · Reply

PSDL75 Jul. 24 at 1:44 PM

$MGNX welp...if you're bullish it is a buying opportunity or you made a mistake...

0 · Reply

Budman10 Jul. 23 at 9:12 PM

$MGNX Why it is Good News Clear Efficacy Signal: Meeting the pre-specified Stage 1 threshold proves the drug is showing enough early anti-tumor activity in squamous cell carcinoma of the head and neck (SCCHN) to warrant expanding the study. Excellent Safety Data: Antibody-drug conjugates (ADCs) often struggle with severe toxicities. Reporting zero cases of interstitial lung disease (ILD) or ocular toxicity is a massive win for MGC026’s safety profile. De-risks the Pipeline: Following past setbacks with earlier assets, this successful progression helps validate MacroGenics’ updated ADC platform and de-risks the upcoming major data presentation in October.

1 · Reply

divyadutta Jul. 23 at 8:14 PM

$MGNX

1 · Reply

chole1 Jul. 23 at 6:23 PM

$MGNX have added in recent days on weakness, but every day the beating towards the close feels off. Anything I did miss why we have not heard yet about the "mid 2026 update" for 026?

0 · Reply

drewskistock Jul. 23 at 3:05 PM

$MGNX

0 · Reply

chole1 Jul. 23 at 2:15 PM

$MGNX what a bad couple of days... underperforming every day and trading well below cash!! WHERE IS THE UPDATE?

1 · Reply

Cello69 Jul. 22 at 6:24 PM

$MGNX "Relative strength BUY'" today on Chaiken. For what its worth. Adding !

1 · Reply

Market Cap	247.90M
Revenue (ttm)	149.50M
Net Income (ttm)	-74.62M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-49.91%
Debt to Equity Ratio	0.00

Volume	296,600
Avg Vol	959,694
Day's Range	N/A - N/A
Shares Out	63.56M
Stochastic %K	89%
Beta	1.20
Analysts	Sell
Price Target	$6.75